Cathetrix presents new catheter stabiliser at Medica
Cathetrix, a developer of urinary (Foley) smart catheter fixations, is presenting its new catheter stabiliser for prevention of UTIs and accidental Foley catheter extractions at Medica 2021.
Medical equipment distributors, urologists and medical providers are invited to watch live demonstrations at Cathetrix Booth J28 in Hall 16.
Foley/Safe 2.0 prevents catheter dislodgement and movement to reduce the risk of catheter associated urinary tract infection (UTI). The catheter stabiliser prevents unintentional and accidental urinary catheter extraction, thus avoiding damage and strictures to the bladder or urethra. Once the Foley catheter is pulled with a force that can harm the patient, Foley/Safe will cut the sterile fluid tube and let the retention balloon deflate, permitting the catheter to slide out safely.
Tal Hadass, chief marketing officer at Cathetrix, said: “After many months of development, we are very proud to launch the second version of our catheter stabiliser, which proved itself in preventing UTIs and accidental Foley catheter extractions. Medica is an excellent opportunity for us to meet personally again with potential clients and demonstrate the effectiveness of Foley/Safe 2.0.”
Foley/Safe 2.0 provides two-layer protection securement to patients with Foley catheters, latex and silicone. The product aims to offer the following advantages:
- Easy to use
- Stabilise the catheter
- Prevents excessive movement
- Simple to attach
- Prevents accidental catheter extraction
- Saves hospitalisation time
Medical studies have shown that 11–17% of all catheters are unintentionally extracted and 5% of all urological catheters are traumatically pulled out.
Some 25% of all hospitalised patients, as well as people confined to bed in hospices and nursing homes, have urinary catheters. Many of these inpatients tend to dislodge their catheter tube, thereby causing themselves unnecessary pain, injury and increased risk of damage and infections.
Foley/Safe 2.0 safely prevents surgery and expensive hospitalisation. The device has been patented and has received US FDA and EU CE mark clearances.